Correction to: Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort (Critical Care, (2021), 25, 1, (177), 10.1186/s13054-021-03588-4)

Nseir S., Martin-Loeches I., Povoa P., Metzelard M., Du Cheyron D., Lambiotte F., Tamion F., Labruyere M., Makris D., Boulle Geronimi C., Pinetonde Chambrun M., Nyunga M., Pouly O., Mégarbane B., Saade A., Gomà G., Magira E., Llitjos J.-F., Torres A., Ioannidou I., Pierre A., Coelho L., Reignier J., Garot D., Kreitmann L., Baudel J.-L., Voiriot G., Contou D., Beurton A., Asfar P., Boyer A., Thille A.W., Mekontso-Dessap A., Tsolaki V., Vinsonneau C., Floch P.-E., Le Guennec L., Ceccato A., Artigas A., Bouchereau M., Labreuche J., Duhamel A., Rouzé A., Favory R., Préau S., Jourdain M., Poissy J., Leger P.S., Van der Linden T., Veinstein A., Azoulay E., Pene F., Martin M., Razazi K., Plantefeve G., Fartoukh M., Thevenin D., Guidet B., Weiss N., Kouatchet A., Salmon C., Brunin G., Nemlaghi S., Meguerditchian D., Argaud L., Voicu S., Luyt C.-E., Kowalski B., Moglia E., Morales L., Koutsoukou A., Mentzelopoulos S.D., Nora D., Boyd S., Maizel J., Cuchet P., Delforge Q., Quenot J.-P., Boyer D., Cilloniz C., the coVAPid study group

Συγγραφέας

Nseir S., Martin-Loeches I., Povoa P., Metzelard M., Du Cheyron D., Lambiotte F., Tamion F., Labruyere M., Makris D., Boulle Geronimi C., Pinetonde Chambrun M., Nyunga M., Pouly O., Mégarbane B., Saade A., Gomà G., Magira E., Llitjos J.-F., Torres A., Ioannidou I., Pierre A., Coelho L., Reignier J., Garot D., Kreitmann L., Baudel J.-L., Voiriot G., Contou D., Beurton A., Asfar P., Boyer A., Thille A.W., Mekontso-Dessap A., Tsolaki V., Vinsonneau C., Floch P.-E., Le Guennec L., Ceccato A., Artigas A., Bouchereau M., Labreuche J., Duhamel A., Rouzé A., Favory R., Préau S., Jourdain M., Poissy J., Leger P.S., Van der Linden T., Veinstein A., Azoulay E., Pene F., Martin M., Razazi K., Plantefeve G., Fartoukh M., Thevenin D., Guidet B., Weiss N., Kouatchet A., Salmon C., Brunin G., Nemlaghi S., Meguerditchian D., Argaud L., Voicu S., Luyt C.-E., Kowalski B., Moglia E., Morales L., Koutsoukou A., Mentzelopoulos S.D., Nora D., Boyd S., Maizel J., Cuchet P., Delforge Q., Quenot J.-P., Boyer D., Cilloniz C., the coVAPid study group

Ημερομηνία

2021

Γλώσσα

DOI

10.1186/s13054-021-03713-3

Λέξη-κλειδί

erratum

BioMed Central Ltd

Εμφάνιση Μεταδεδομένων

Επιτομή

Following publication of the original article [1], the authors identified an error in the Abstract and Results section. The correct numbers and text are given hereafter. Abstract VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 group (adjusted HR 1.65 (95% CI 1.11–2.46), p = 0.013), but not in influenza (1.74 (0.99–3.06), p = 0.052), or no viral infection groups (1.13 (0.68–1.86), p = 0.63). Results Primary and secondary outcomes: VAP was associated with higher risk for 28-day mortality in in SARS-CoV-2 group, but not in the two other groups (Fig. 2A). All the changes that were requested are implemented in this correction and the original article [1] has been corrected. © The Author(s) 2021

URI

http://hdl.handle.net/11615/77264

Collections

Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19743]